Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Hulio(Cf) Pen(Adalimumab-Fkjp)Viatris Inc. logoVTRS

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Viatris Inc.

$132K

Medicare cost, 2024

Medicare drug plans spent $131,908 on Hulio(Cf) Pen (adalimumab-fkjp) in 2024, for 12 prescriptions and refills. At about $10,992 per prescription it is a high-cost drug. It is made by Viatris Inc. (VTRS).

Medicare cost, 2024

$132K

Prescriptions

12

$10,992.33 per claim

Patients

-

5 prescribers

Total spending, 2024

$132K

- per patient

Questions and answers

How much does Medicare spend on Hulio(Cf) Pen?

Medicare prescription drug plans paid $132K for Hulio(Cf) Pen in 2024, for 12 prescriptions and refills to - patients. The average cost per claim was $10,992.33.

Who makes Hulio(Cf) Pen?

Hulio(Cf) Pen is made by Viatris Inc. (VTRS), listed in the Medicare spending data as Mylan Spec/Bioc.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Prescriber data by year

YearPrescribersClaimsPatientsCost
2024512-$132K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Mylan Spec/BiocVTRS logoVTRS12$132K

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube